ESR1 and endometrial cancer: The binding of DES to estrogen receptors (ER) also affects the expression of genes in the uterine myometrium, inducing its hyper-responsiveness to sex hormones, increasing the risk for uterine leiomyoma later in life and endometrial cancer in young and menopausal women [5,27,28,29,30].